MDMA's empathogenic effects on social and emotional processing to be characterized in healthy humans

Despite widespread recreational use of MDMA (ecstasy) and user reports of profound empathy and closeness, its specific 'empathogenic' effects on social and emotional processing remain poorly characterized in controlled settings. Current understanding of MDMA's distinctive neurochemical profile, involving serotonin (5-HT) and oxytocin release, suggests a unique mechanism beyond typical stimulants. This gap in controlled research hinders a full public health assessment and understanding of its potential therapeutic applications, particularly in areas like post-traumatic stress disorder (PTSD) where enhanced prosocial behaviors could be beneficial.

Investigators propose a controlled laboratory study in 100 healthy volunteers with prior ecstasy use to characterize MDMA's effects. Participants will receive MDMA (0.75 mg/kg or 1.5 mg/kg, up to 125 mg total) or a placebo, with oxytocin (20 IU) serving as an active control. The study will assess effects on measures of emotion recognition, emotional responsiveness, and sociability, which are hypothesized to contribute to MDMA's 'empathogenic' profile. The design aims to isolate and quantify these specific social and emotional processing changes.

This abstract describes the aims and proposed methodology for a study investigating MDMA's effects on social and emotional processing; it does not present any findings or results. Therefore, no specific data, percentages, p-values, or fold-changes are available from this record. The study is designed to characterize how MDMA influences measures such as emotion recognition, emotional responsiveness, and sociability, which are believed to underpin its reported 'empathogenic' effects. The investigators intend to compare MDMA's impact against both placebo and an active control, oxytocin, to better understand its unique neurochemical profile and behavioral outcomes.